CanaFarma Hemp Products Corp. announced that it is expanding its functional confectionary line under the YOOFORIC™ brand and launching two new hemp oil-infused chewing gums this July.

These two new gums are called YOOFORIC Rise for the morning, and YOOFORIC Pillow Talk for the evening. 

YOOFORIC RISE AM will start your day right with a boost of ENERGY, and a sense of calm focus! This Chill Mint Chewing Gum contains a unique blend of Full Spectrum Hemp Oil with naturally occurring CBD, Green Tea, Omega-3 Fatty Acids (DHA and EPA), L-tryptophan, Vitamin B3, Vitamin C, and Magnesium Citrate to help support the body’s endocannabinoid system, which is responsible for assisting the body reach homeostasis! With an 80% bioavailability rate, it acts fast, absorbing in 2 – 10 minutes! 

YOOFORIC Pillow Talk PM, is cinnamon flavored and is infused with a calming blend of hemp extract, melatonin, L-Tryptophan, and Vitamin B3, which also helps support the body’s endocannabinoid system rest the mind for a relaxed night of sleep. Each piece of gum delivers 250 mg of Full-Spectrum Hemp Oil, including 5 mg of naturally occurring CBD, and also quickly absorbs in 2-10 minutes with the same 80% bioavailability rate. 

With both premium quality chewing gums targeted for a unique function, CanaFarma will continue its objective of leading the charge with industry-leading, unique delivery methods, resulting in the highest levels of bioavailability without a prescription. As CBD helps fight pain, inflammation, and seizures, additional studies show that medicated CBD chewing gum may help to decrease pain in patients with IBS.

Currently, CanaFarma produces five other products under their brands YOOFORIC and State of Mind, including their most popular product, a full spectrum chewing gum with an industry-leading absorption rate of 84%. They have two hemp oil tinctures, and two pain-relieving creams, and are now adding their new skincare line which will be released by the end of June.

This April, CanaFarma signed a Letter of Intent to acquire PharmOps Ltd., and it’s its cGMP (current Good Manufacturing Practices) licensed facility in New Jersey to produce more pharmaceutical and nutraceutical products. Since signing the Letter of Intent, they have developed a successful vertical integration plan of direct-to-consumer marketing which will set them apart from their competitors. This marketing initiative not only works to produce CanaFarma’s own hemp oil, but functions as a supplier, manufacturer, wholesaler, distributor, and retailer. CanaFarma’s extensive experience and knowledge set to prepare them to take on the challenge and rapidly scale.